BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 32319336)

  • 1. Distinct Characteristics of VEGF-D and VEGF-C to Predict Mortality in Patients With Suspected or Known Coronary Artery Disease.
    Wada H; Suzuki M; Matsuda M; Ajiro Y; Shinozaki T; Sakagami S; Yonezawa K; Shimizu M; Funada J; Takenaka T; Morita Y; Nakamura T; Fujimoto K; Matsubara H; Kato T; Unoki T; Takagi D; Wada K; Wada M; Iguchi M; Masunaga N; Ishii M; Yamakage H; Kusakabe T; Yasoda A; Shimatsu A; Kotani K; Satoh-Asahara N; Abe M; Akao M; Hasegawa K;
    J Am Heart Assoc; 2020 May; 9(9):e015761. PubMed ID: 32319336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VEGF-C and Mortality in Patients With Suspected or Known Coronary Artery Disease.
    Wada H; Suzuki M; Matsuda M; Ajiro Y; Shinozaki T; Sakagami S; Yonezawa K; Shimizu M; Funada J; Takenaka T; Morita Y; Nakamura T; Fujimoto K; Matsubara H; Kato T; Unoki T; Takagi D; Ura S; Wada K; Iguchi M; Masunaga N; Ishii M; Yamakage H; Shimatsu A; Kotani K; Satoh-Asahara N; Abe M; Akao M; Hasegawa K;
    J Am Heart Assoc; 2018 Nov; 7(21):e010355. PubMed ID: 30554564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardio-Renal Biomarker Soluble Urokinase-Type Plasminogen Activator Receptor Is Associated With Cardiovascular Death and Myocardial Infarction in Patients With Coronary Artery Disease Independent of Troponin, C-Reactive Protein, and Renal Function.
    Nikorowitsch J; Borchardt T; Appelbaum S; Ojeda F; Lackner KJ; Schnabel RB; Blankenberg S; Zeller T; Karakas M
    J Am Heart Assoc; 2020 Apr; 9(8):e015452. PubMed ID: 32299288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect Modification of Chronic Kidney Disease on the Association of Circulating and Imaging Cardiac Biomarkers With Outcomes.
    Gregg LP; Adams-Huet B; Li X; Colbert G; Jain N; de Lemos JA; Hedayati SS
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28679558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of cardiac biomarker score for risk stratification in stable patients undergoing elective cardiac evaluation across glycemic status.
    Tang WH; Iqbal N; Wu Y; Hazen SL
    Am J Cardiol; 2013 Feb; 111(4):465-70. PubMed ID: 23219176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-Molecule Counting of High-Sensitivity Troponin I in Patients Referred for Diagnostic Angiography: Results From the CASABLANCA (Catheter Sampled Blood Archive in Cardiovascular Diseases) Study.
    McCarthy CP; Ibrahim NE; Lyass A; Li Y; Gaggin HK; Simon ML; Mukai R; Gandhi P; Kelly N; Motiwala SR; van Kimmenade RRJ; Massaro JM; D'Agostino RB; Januzzi JL
    J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29519811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-type natriuretic peptide trumps other prognostic markers in patients assessed for coronary disease.
    Kotecha D; Flather MD; Atar D; Collins P; Pepper J; Jenkins E; Reid CM; Eccleston D;
    BMC Med; 2019 Apr; 17(1):72. PubMed ID: 30943979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble Urokinase-Type Plasminogen Activator Receptor and High-Sensitivity Troponin Levels Predict Outcomes in Nonobstructive Coronary Artery Disease.
    Al-Badri A; Tahhan AS; Sabbak N; Alkhoder A; Liu C; Ko YA; Vaccarino V; Martini A; Sidoti A; Goodwin C; Ghazzal B; Beshiri A; Murtagh G; Mehta PK; Quyyumi AA
    J Am Heart Assoc; 2020 Apr; 9(8):e015515. PubMed ID: 32301366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galectin-3 predicts long-term cardiovascular death in high-risk patients with coronary artery disease.
    Maiolino G; Rossitto G; Pedon L; Cesari M; Frigo AC; Azzolini M; Plebani M; Rossi GP
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):725-32. PubMed ID: 25614283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Bioavailable and Free 25-Hydroxyvitamin D Levels, but Not Its Total Level, Are Associated With the Risk of Mortality in Patients With Coronary Artery Disease.
    Yu C; Xue H; Wang L; Chen Q; Chen X; Zhang Y; Hu G; Ling W
    Circ Res; 2018 Sep; 123(8):996-1007. PubMed ID: 30355032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial.
    Redfors B; Chen S; Crowley A; Ben-Yehuda O; Gersh BJ; Lembo NJ; Brown WM; Banning AP; Taggart DP; Serruys PW; Kappetein AP; Sabik JF; Stone GW
    Circulation; 2018 Jul; 138(5):469-478. PubMed ID: 29666071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SuPAR is associated with death and adverse cardiovascular outcomes in patients with suspected coronary artery disease.
    Hodges G; Lyngbæk S; Selmer C; Ahlehoff O; Theilade S; Sehestedt TB; Abildgaard U; Eugen-Olsen J; Galløe AM; Hansen PR; Jeppesen JL; Bang CN
    Scand Cardiovasc J; 2020 Dec; 54(6):339-345. PubMed ID: 32400206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary artery calcification scoring system based on the coronary artery calcium data and reporting system (CAC-DRS) predicts major adverse cardiovascular events or all-cause death in patients with potentially curable lung cancer without a history of cardiovascular disease.
    Osawa K; Bessho A; Fuke S; Moriyama S; Mizobuchi A; Daido S; Tanaka M; Yumoto A; Saito H; Ito H
    Heart Vessels; 2020 Nov; 35(11):1483-1493. PubMed ID: 32444933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of soluble suppression of tumorigenesis-2 (sST2) for cardiovascular events in coronary artery disease patients with and without diabetes mellitus.
    Li M; Duan L; Cai Y; Hao B; Chen J; Li H; Liu H
    Cardiovasc Diabetol; 2021 Feb; 20(1):49. PubMed ID: 33608010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-sensitivity troponin I and B-type natriuretic peptide biomarkers for prediction of cardiovascular events in patients with coronary artery disease with and without diabetes mellitus.
    Wong YK; Cheung CYY; Tang CS; Hai JSH; Lee CH; Lau KK; Au KW; Cheung BMY; Sham PC; Xu A; Lam KSL; Tse HF
    Cardiovasc Diabetol; 2019 Dec; 18(1):171. PubMed ID: 31847896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD): A Randomized Superiority Trial.
    Taguchi I; Iimuro S; Iwata H; Takashima H; Abe M; Amiya E; Ogawa T; Ozaki Y; Sakuma I; Nakagawa Y; Hibi K; Hiro T; Fukumoto Y; Hokimoto S; Miyauchi K; Yamazaki T; Ito H; Otsuji Y; Kimura K; Takahashi J; Hirayama A; Yokoi H; Kitagawa K; Urabe T; Okada Y; Terayama Y; Toyoda K; Nagao T; Matsumoto M; Ohashi Y; Kaneko T; Fujita R; Ohtsu H; Ogawa H; Daida H; Shimokawa H; Saito Y; Kimura T; Inoue T; Matsuzaki M; Nagai R
    Circulation; 2018 May; 137(19):1997-2009. PubMed ID: 29735587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma C20-Sphingolipids predict cardiovascular events independently from conventional cardiovascular risk factors in patients undergoing coronary angiography.
    Othman A; Saely CH; Muendlein A; Vonbank A; Drexel H; von Eckardstein A; Hornemann T
    Atherosclerosis; 2015 May; 240(1):216-21. PubMed ID: 25801014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathway-Specific Aggregate Biomarker Risk Score Is Associated With Burden of Coronary Artery Disease and Predicts Near-Term Risk of Myocardial Infarction and Death.
    Ghasemzedah N; Hayek SS; Ko YA; Eapen DJ; Patel RS; Manocha P; Al Kassem H; Khayata M; Veledar E; Kremastinos D; Thorball CW; Pielak T; Sikora S; Zafari AM; Lerakis S; Sperling L; Vaccarino V; Epstein SE; Quyyumi AA
    Circ Cardiovasc Qual Outcomes; 2017 Mar; 10(3):. PubMed ID: 28280039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Plasma Concentrations of Soluble ST2 Independently Predict Mortality but not Cardiovascular Events in Stable Coronary Heart Disease Patients: 13-Year Follow-up of the KAROLA Study.
    Pfetsch V; Sanin V; Jaensch A; Dallmeier D; Mons U; Brenner H; Koenig W; Rothenbacher D
    Cardiovasc Drugs Ther; 2017 Apr; 31(2):167-177. PubMed ID: 28283847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting risk of coronary events and all-cause mortality: role of B-type natriuretic peptide above traditional risk factors and coronary artery calcium scoring in the general population: the Heinz Nixdorf Recall Study.
    Kara K; Mahabadi AA; Berg MH; Lehmann N; Möhlenkamp S; Kälsch H; Bauer M; Moebus S; Dragano N; Jöckel KH; Neumann T; Erbel R
    Eur J Prev Cardiol; 2014 Sep; 21(9):1171-9. PubMed ID: 23674833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.